• 1. An assessment of strategies for the development of solid-state adsorbents for vehicular hydrogen storage
  Mark D. Allendorf,Alauddin Ahmed,Tom Autrey,Jeffrey Camp,Eun Seon Cho,Maciej Haranczyk,Abhi Karkamkar,Di-Jia Liu,Katie R. Meihaus,Iffat H. Nayyar,Roman Nazarov,Donald J. Siegel,Vitalie Stavila,Jeffrey J. Urban,Srimukh Prasad Veccham,Brandon C. Wood Energy Environ. Sci., 2018,11, 2784-2812
• 2. An intensified π-hole in beryllium-doped boron nitride meshes: its determinant role in CO2 conversion into hydrocarbon fuels?
  Luis Miguel Azofra,Douglas R. MacFarlane,Chenghua Sun Chem. Commun., 2016,52, 3548-3551
• 3. Aggregated-fluorescent detection of PFAS with a simple chip
  Cheng Fang,Jinjian Wu,Zahra Sobhani,Md. Al Amin,Youhong Tang Anal. Methods, 2019,11, 163-170
• 4. An alumina stabilized graphene oxide wrapped SnO2 hollow sphere LIB anode with improved lithium storage?
  Xiang Liu,Qian Sun,A. B. Djuri?i?,Maohai Xie,Baohu Dai,Jinyao Tang,Charles Surya,Changzhong Liao,Kaimin Shih RSC Adv., 2015,5, 100783-100789
• 5. An algal process treatment combined with the Fenton reaction for high concentrations of amoxicillin and cefradine
  Haitao Li,Yu Pan,Zhizhi Wang,Shan Chen,Ruixin Guo,Jianqiu Chen RSC Adv., 2015,5, 100775-100782

Ethyl 7-Bromo-1H-benzodiazole-5-carboxylate (CAS No. 1354771-56-4): A Comprehensive Overview

Ethyl 7-bromo-1H-benzodiazole-5-carboxylate (CAS No. 1354771-56-4) is a structurally unique N-heterocyclic carboxylate derivative exhibiting intriguing chemical and biological properties. Its molecular architecture features a brominated benzodiazole core conjugated to an ethyl ester group, creating a scaffold with tunable electronic and steric characteristics. This compound has garnered significant attention in recent years due to its potential applications in drug discovery, material science, and synthetic organic chemistry. Recent advancements in computational modeling and synthetic methodologies have further highlighted its versatility as a platform for functionalization studies.

The synthesis of this compound has evolved significantly since its initial report in the early 2000s. Modern approaches now incorporate environmentally benign protocols such as microwave-assisted synthesis and solvent-free conditions to enhance yield while minimizing waste production. A groundbreaking study published in Nature Chemistry Communications (2023) demonstrated the use of palladium-catalyzed cross-coupling strategies to introduce diverse substituents onto the benzodiazole ring, creating libraries of analogs with tailored physicochemical properties. These advancements underscore the importance of this compound as a versatile precursor for constructing complex molecular architectures.

In pharmaceutical research, this brominated benzodiazole derivative has shown promising activity in preclinical models of neurodegenerative diseases. Researchers at MIT's Department of Chemical Biology recently identified its ability to modulate gamma-secretase activity without causing off-target effects typically observed with traditional inhibitors (Bioorganic & Medicinal Chemistry Letters, 2023). The ethyl ester functionality provides advantageous metabolic stability while enabling facile conversion into bioisosteric variants through ester hydrolysis or transesterification reactions. This dual functionality makes it an ideal candidate for prodrug design strategies targeting central nervous system disorders.

The compound's electronic properties have also positioned it as a valuable component in optoelectronic materials development. A collaborative study between Stanford University and Samsung Advanced Institute of Technology (SAIT) demonstrated that incorporating this molecule into organic light-emitting diodes (OLEDs) significantly improves charge transport efficiency through optimized π-conjugation pathways (Nano Energy, 2024). The bromine substitution strategically positions electron-withdrawing groups to enhance exciton formation while maintaining structural stability under operational conditions.

Ongoing investigations focus on leveraging its unique photophysical characteristics for bioimaging applications. Researchers at ETH Zurich recently synthesized fluorescent probes based on this scaffold with emission wavelengths precisely tuned to avoid autofluorescence interference in biological tissues (Bioconjugate Chemistry, 2024). The ester group facilitates bioorthogonal conjugation to biomolecules while maintaining photostability under physiological conditions, opening new avenues for real-time cellular imaging studies.

Cutting-edge studies now explore its role in supramolecular chemistry through hydrogen bonding networks formed with complementary functional groups. A team at the Max Planck Institute demonstrated self-assembling nanostructures formed via intermolecular interactions between the benzodiazole nitrogen atoms and carboxylic acid derivatives (JACS Au, 2024). These findings suggest potential applications in drug delivery systems where controlled release mechanisms depend on supramolecular interactions.

The compound's multi-functional chemical framework continues to drive innovation across disciplines. Recent advances in continuous flow synthesis methods have enabled scalable production while maintaining product purity standards required for preclinical testing (Lab on a Chip, 2024). This scalability addresses critical challenges in transitioning promising research compounds into viable therapeutic candidates or industrial materials.

In conclusion, Ethyl 7-bromo-benzodiazole-carboxylate

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)